$510M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | KINIKSA PHARMACEUTICALS INTL Kiniksa Pharmaceuticals Intl | 918,070 | +20.6% | $59M | 11.5% |
| 2 | RLAY Relay Therapeutics Inc | 3.0M | +0.0% | $56M | 11.0% |
| 3 | LBRX Lb Pharmaceuticals Inc | 1.4M | +0.0% | $45M | 8.8% |
| 4 | RLMD Relmada Therapeutics Inc | 6.4M | +2.1% | $44M | 8.7% |
| 5 | ANRO Alto Neuroscience Inc | 1.4M | +2.1% | $36M | 7.0% |
| 6 | DNTH Dianthus Therapeutics Inc | 354,816 | −4.9% | $35M | 6.8% |
| 7 | ALKS Alkermes Plc | 543,876 | +71.0% | $28M | 5.6% |
| 8 | SVRA Savara Inc | 3.5M | +2.1% | $21M | 4.2% |
| 9 | PCVX Vaxcyte Inc | 306,047 | +24.6% | $18M | 3.5% |
| 10 | ELVN Enliven Therapeutics Inc | 329,006 | +0.0% | $17M | 3.3% |
| 11 | ENTA Enanta Pharmaceuticals Inc | 1.1M | +16.7% | $16M | 3.1% |
| 12 | CATX Perspective Therapeutics Inc | 3.7M | +40.6% | $13M | 2.5% |
| 13 | INFLARX NV Inflarx Nv | 5.4M | — | $12M | 2.4% |
| 14 | SRZN Surrozen Inc | 432,040 | +0.0% | $11M | 2.2% |
| 15 | ALMS Alumis Inc | 392,574 | +0.0% | $11M | 2.2% |
| 16 | IPSC Century Therapeutics Inc | 4.1M | +0.0% | $10M | 2.0% |
| 17 | NERV Minerva Neurosciences Inc | 1.7M | +0.0% | $9M | 1.8% |
| 18 | SABS Sab Biotherapeutics Inc | 2.2M | +0.0% | $9M | 1.7% |
| 19 | ANTX An2 Therapeutics Inc | 1.7M | +0.0% | $8M | 1.6% |
| 20 | ERAS Erasca Inc | 422,543 | +0.0% | $8M | 1.5% |
| 21 | IKT Inhibikase Therapeutics Inc | 3.6M | +0.0% | $7M | 1.4% |
| 22 | RACC Research Alliance Corp Iii | 500,000 | — | $5M | 1.0% |
| 23 | HLXC Helix Acquisition Corp Iii | 500,000 | +0.0% | $5M | 1.0% |
| 24 | ZLAB Zai Lab Ltd | 279,110 | — | $5M | 1.0% |
| 25 | QUIT Achieve Life Science Inc | 736,637 | — | $5M | 0.9% |
| 26 | LXEO Lexeo Therapeutics Inc | 928,593 | +0.0% | $4M | 0.8% |
| 27 | ALEC Alector Inc | 2.1M | +0.0% | $4M | 0.8% |
| 28 | LONA Leonabio Inc | 393,701 | +0.0% | $4M | 0.7% |
| 29 | CRVS Corvus Pharmaceuticals Inc | 231,585 | +0.0% | $3M | 0.7% |
| 30 | JATT Jatt Ii Acquisition Corp | 160,000 | — | $2M | 0.4% |